Sign in

CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 1235 430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  2. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  3. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  4. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  5. 4 Open-market buy 10% owner bought 1,268,508 shares at an average $1.91 ($2,417,847)
  6. 4 Open-market sale Chief Financial Officer sold 600,000 shares at $1.71 ($1,026,000)
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations · Other events
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13D/A Stake Beneficial Ownership Report
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 29 of 41 · 808 filings